Clearwave Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$839K Buy
725
+62
+9% +$73.2K 0.44% 49
2026
Q2
$796K Buy
663
+100
+18% +$102K 0.44% 52
2026
Q1
$517K Buy
563
+82
+17% +$83.1K 0.35% 66
2025
Q4
$517K Buy
+481
New +$460K 0.38% 69

Other funds holding LLY

Clearwave Capital's LLY Position: Q3 2026 in Review

Clearwave Capital increased its Eli Lilly (LLY) stake by 9.4% in Q3 2026, buying an estimated $73.2K and bringing the position to 725 shares worth $839K. The position accounts for 0.44% of the portfolio, ranked #49.

Clearwave Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Clearwave Capital held 725 shares of Eli Lilly worth $839K as of Q3 2026.
  • Clearwave Capital bought 62 Eli Lilly shares in Q3 2026, an estimated $73.2K.
  • Eli Lilly made up 0.44% of Clearwave Capital's portfolio in Q3 2026, its #49 holding.
  • Clearwave Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Clearwave Capital's 13F filing for Q3 2026, filed 27 Oct 2026.